Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)
- 1 April 2001
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 32 (1), 61-69
- https://doi.org/10.1016/s0169-5002(00)00205-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideThe New England Journal of Medicine, 1999
- Enzyme‐linked Immunosorbent Assay of Pro‐gastrin‐releasing Peptide for Small Cell Lung Cancer Patients in Comparison with Neuron‐specific Enolase MeasurementJapanese Journal of Cancer Research, 1995
- Peptide Hormone Production in Primary Lung TumorsPublished by Springer Science and Business Media LLC ,1985
- A method of comparing the areas under receiver operating characteristic curves derived from the same cases.Radiology, 1983
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982
- SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCERThe Lancet, 1982
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978
- A gastrin releasing peptide from the porcine nonantral gastric tissue.Gut, 1978
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958